![](/img/cover-not-exists.png)
Letrozole (femara) is a more effective inhibitor of estrogen activity than tamoxifen: Evidence from a randomized phase III trial of 4 months preoperative endocrine therapy for postmenopausal women with primary invasive breast cancer
M.J. Ellis, B. Sing, W.R. Miller, A. Llombart-Cussac, F. Janicke, D.B. Evans, M. Borgs, E. Quebe-Fehling, C. Brady, M. Dugan, A. CoopVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)80054-x
File:
PDF, 135 KB
english, 2001